{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:48:19Z","timestamp":1785466099785,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000147","name":"Canadian Breast Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s10549-016-4038-y","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T09:53:12Z","timestamp":1477907592000},"page":"135-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel"],"prefix":"10.1007","volume":"161","author":[{"given":"Olivia","family":"Moran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Nikitina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Royer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aletta","family":"Poll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Narod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad R.","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Kotsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"issue":"9","key":"4038_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrc1431","volume":"4","author":"SA Narod","year":"2004","unstructured":"Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4(9):665\u2013676. doi: 10.1038\/nrc1431","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"4038_CR2","first-page":"232","volume":"48","author":"EB Claus","year":"1991","unstructured":"Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48(2):232\u2013242","journal-title":"Am J Hum Genet"},{"issue":"3","key":"4038_CR3","first-page":"395","volume":"9","author":"D Easton","year":"1990","unstructured":"Easton D, Peto J (1990) The contribution of inherited predisposition to cancer incidence. Cancer Surv 9(3):395\u2013416","journal-title":"Cancer Surv"},{"issue":"1","key":"4038_CR4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/bcr6","volume":"1","author":"DF Easton","year":"1999","unstructured":"Easton DF (1999) How many more breast cancer predisposition genes are there? Breast Cancer Res 1(1):14\u201317","journal-title":"Breast Cancer Res"},{"issue":"3","key":"4038_CR5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676\u2013689","journal-title":"Am J Hum Genet"},{"issue":"23","key":"4038_CR6","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/jnci\/djj465","volume":"98","author":"HA Risch","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98(23):1694\u20131706. doi: 10.1093\/jnci\/djj465","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"4038_CR7","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.20.4.994","volume":"20","author":"HA Shih","year":"2002","unstructured":"Shih HA, Couch FJ, Nathanson KL, Blackwood MA, Rebbeck TR, Armstrong KA, Calzone K, Stopfer J, Seal S, Stratton MR, Weber BL (2002) BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J Clin Oncol 20(4):994\u2013999","journal-title":"J Clin Oncol"},{"issue":"4","key":"4038_CR8","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/bcr2919","volume":"13","author":"DE Goldgar","year":"2011","unstructured":"Goldgar DE, Healey S, Dowty JG, Da Silva L, Chen X, Spurdle AB, Terry MB, Daly MJ, Buys SM, Southey MC, Andrulis I, John EM, Khanna KK, Hopper JL, Oefner PJ, Lakhani S, Chenevix-Trench G (2011) Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Res 13(4):R73. doi: 10.1186\/bcr2919","journal-title":"Breast Cancer Res"},{"issue":"1","key":"4038_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10549-011-1403-8","volume":"131","author":"M Ratajska","year":"2012","unstructured":"Ratajska M, Antoszewska E, Piskorz A, Brozek I, Borg A, Kusmierek H, Biernat W, Limon J (2012) Cancer predisposing BARD1 mutations in breast-ovarian cancer families. Breast Cancer Res Treat 131(1):89\u201397. doi: 10.1007\/s10549-011-1403-8","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"4038_CR10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/ng1902","volume":"38","author":"S Seal","year":"2006","unstructured":"Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, Chagtai T, Jayatilake H, Ahmed M, Spanova K, North B, McGuffog L, Evans DG, Eccles D, Easton DF, Stratton MR, Rahman N (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38(11):1239\u20131241. doi: 10.1038\/ng1902","journal-title":"Nat Genet"},{"issue":"7","key":"4038_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/jmedgenet-2012-101472","volume":"50","author":"PR Benusiglio","year":"2013","unstructured":"Benusiglio PR, Malka D, Rouleau E, De Pauw A, Buecher B, Nogues C, Fourme E, Colas C, Coulet F, Warcoin M, Grandjouan S, Sezeur A, Laurent-Puig P, Moliere D, Tlemsani C, Di Maria M, Byrde V, Delaloge S, Blayau M, Caron O (2013) CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet 50(7):486\u2013489. doi: 10.1136\/jmedgenet-2012-101472","journal-title":"J Med Genet"},{"issue":"7","key":"4038_CR12","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.7314\/APJCP.2012.13.7.3501","volume":"13","author":"Y Yang","year":"2012","unstructured":"Yang Y, Zhang F, Wang Y, Liu SC (2012) CHEK2 1100delC variant and breast cancer risk in Caucasians: a meta-analysis based on 25 studies with 29,154 cases and 37,064 controls. Asian Pac J Cancer Prev 13(7):3501\u20133505","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"4038_CR13","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/bcr1828","volume":"9","author":"WD Foulkes","year":"2007","unstructured":"Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E, Robidoux A, Martin G, Bismar TA, Tischkowitz M, Rousseau F, Narod SA (2007) Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res 9(6):R83. doi: 10.1186\/bcr1828","journal-title":"Breast Cancer Res"},{"issue":"7432","key":"4038_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nature11725","volume":"493","author":"E Ruark","year":"2013","unstructured":"Ruark E, Snape K, Humburg P, Loveday C, Bajrami I, Brough R, Rodrigues DN, Renwick A, Seal S, Ramsay E, Duarte Sdel V, Rivas MA, Warren-Perry M, Zachariou A, Campion-Flora A, Hanks S, Murray A, Ansari Pour N, Douglas J, Gregory L, Rimmer A, Walker NM, Yang TP, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Brice G, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Eccles D, Evans DG, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison PJ, Paterson J, Porteous M, Rogers MT, Shanley S, Walker L, Gore M, Houlston R, Brown MA, Caufield MJ, Deloukas P, McCarthy MI, Todd JA, Turnbull C, Reis-Filho JS, Ashworth A, Antoniou AC, Lord CJ, Donnelly P, Rahman N (2013) Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature 493(7432):406\u2013410. doi: 10.1038\/nature11725","journal-title":"Nature"},{"issue":"2","key":"4038_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10549-010-1094-6","volume":"126","author":"L Jiang","year":"2011","unstructured":"Jiang L, Zhang C, Li Y, Yu X, Zheng J, Zou P, Bin X, Lu J, Zhou Y (2011) A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population. Breast Cancer Res Treat 126(2):487\u2013495. doi: 10.1007\/s10549-010-1094-6","journal-title":"Breast Cancer Res Treat"},{"issue":"44","key":"4038_CR16","doi-asserted-by":"publisher","first-page":"18032","DOI":"10.1073\/pnas.1115052108","volume":"108","author":"T Walsh","year":"2011","unstructured":"Walsh T, Casadei S, Lee MK, Pennil CC, Nord AS, Thornton AM, Roeb W, Agnew KJ, Stray SM, Wickramanayake A, Norquist B, Pennington KP, Garcia RL, King MC, Swisher EM (2011) Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci USA 108(44):18032\u201318037. doi: 10.1073\/pnas.1115052108","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4C","key":"4038_CR17","first-page":"3015","volume":"27","author":"C Kanka","year":"2007","unstructured":"Kanka C, Brozek I, Skalska B, Siemiatkowska A, Limon J (2007) Germline NBS1 mutations in families with aggregation of Breast and\/or ovarian cancer from north-east Poland. Anticancer Res 27(4C):3015\u20133018","journal-title":"Anticancer Res"},{"issue":"2","key":"4038_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1399-0004.2009.01309.x","volume":"77","author":"A Blanco","year":"2010","unstructured":"Blanco A, Grana B, Fachal L, Santamarina M, Cameselle-Teijeiro J, Ruiz-Ponte C, Carracedo A, Vega A (2010) Beyond BRCA1 and BRCA2 wild-type breast and\/or ovarian cancer families: germline mutations in TP53 and PTEN. Clin Genet 77(2):193\u2013196. doi: 10.1111\/j.1399-0004.2009.01309.x","journal-title":"Clin Genet"},{"issue":"12","key":"4038_CR19","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1136\/jmg.40.12.e131","volume":"40","author":"K Heikkinen","year":"2003","unstructured":"Heikkinen K, Karppinen SM, Soini Y, Makinen M, Winqvist R (2003) Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility. J Med Genet 40(12):e131","journal-title":"J Med Genet"},{"issue":"4","key":"4038_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1089\/gtmb.2010.0027","volume":"14","author":"F Guenard","year":"2010","unstructured":"Guenard F, Pedneault CS, Ouellette G, Labrie Y, Simard J, Durocher F (2010) Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1\/2 French Canadian families with high risk of breast cancer. Genetic testing and molecular biomarkers 14(4):515\u2013526. doi: 10.1089\/gtmb.2010.0027","journal-title":"Genetic testing and molecular biomarkers"},{"issue":"4","key":"4038_CR21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ajhg.2012.02.027","volume":"90","author":"DJ Park","year":"2012","unstructured":"Park DJ, Lesueur F, Nguyen-Dumont T, Pertesi M, Odefrey F, Hammet F, Neuhausen SL, John EM, Andrulis IL, Terry MB, Daly M, Buys S, Le Calvez-Kelm F, Lonie A, Pope BJ, Tsimiklis H, Voegele C, Hilbers FM, Hoogerbrugge N, Barroso A, Osorio A, Giles GG, Devilee P, Benitez J, Hopper JL, Tavtigian SV, Goldgar DE, Southey MC (2012) Rare mutations in XRCC2 increase the risk of breast cancer. Am J Hum Genet 90(4):734\u2013739. doi: 10.1016\/j.ajhg.2012.02.027","journal-title":"Am J Hum Genet"},{"issue":"10","key":"4038_CR22","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/bjc.2012.452","volume":"107","author":"T Pal","year":"2012","unstructured":"Pal T, Akbari MR, Sun P, Lee JH, Fulp J, Thompson Z, Coppola D, Nicosia S, Sellers TA, McLaughlin J, Risch HA, Rosen B, Shaw P, Schildkraut J, Narod SA (2012) Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer. Br J Cancer 107(10):1783\u20131790. doi: 10.1038\/bjc.2012.452","journal-title":"Br J Cancer"},{"issue":"2","key":"4038_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/sj.bjc.6604830","volume":"100","author":"KA Metcalfe","year":"2009","unstructured":"Metcalfe KA, Finch A, Poll A, Horsman D, Kim-Sing C, Scott J, Royer R, Sun P, Narod SA (2009) Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation. Br J Cancer 100(2):421\u2013425. doi: 10.1038\/sj.bjc.6604830","journal-title":"Br J Cancer"},{"issue":"14","key":"4038_CR24","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25(14):1754\u20131760. doi: 10.1093\/bioinformatics\/btp324","journal-title":"Bioinformatics"},{"key":"4038_CR25","unstructured":"Picard. http:\/\/broadinstitute.github.io\/picard\/ . Accessed 2 Aug 2016"},{"issue":"9","key":"4038_CR26","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20(9):1297\u20131303. doi: 10.1101\/gr.107524.110","journal-title":"Genome Res"},{"issue":"23","key":"4038_CR27","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, Goldgar DE, Evans DG, Chenevix-Trench G, Rahman N, Robson M, Domchek SM, Foulkes WD (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372(23):2243\u20132257. doi: 10.1056\/NEJMsr1501341","journal-title":"N Engl J Med"},{"key":"4038_CR28","unstructured":"National Comprehensive Cancer Network. https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#breast_risk . Accessed 20 June 2016"},{"issue":"6","key":"4038_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/cge.12563","volume":"88","author":"CL Scherr","year":"2015","unstructured":"Scherr CL, Lindor NM, Malo TL, Couch FJ, Vadaparampil ST (2015) Genetic counselors\u2019 practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing. Clin Genet 88(6):523\u2013529. doi: 10.1111\/cge.12563","journal-title":"Clin Genet"},{"issue":"2","key":"4038_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.suronc.2015.04.003","volume":"24","author":"F Aloraifi","year":"2015","unstructured":"Aloraifi F, Boland MR, Green AJ, Geraghty JG (2015) Gene analysis techniques and susceptibility gene discovery in non-BRCA1\/BRCA2 familial breast cancer. Surg Oncol 24(2):100\u2013109. doi: 10.1016\/j.suronc.2015.04.003","journal-title":"Surg Oncol"},{"issue":"8","key":"4038_CR31","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/pbc.25486","volume":"62","author":"B Schlegelberger","year":"2015","unstructured":"Schlegelberger B, Kreipe H, Lehmann U, Steinemann D, Ripperger T, Gohring G, Thomay K, Rump A, Di Donato N, Suttorp M (2015) A child with Li-Fraumeni syndrome: modes to inactivate the second allele of TP53 in three different malignancies. Pediatr Blood Cancer 62(8):1481\u20131484. doi: 10.1002\/pbc.25486","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"4038_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2014.10.008","volume":"41","author":"P Economopoulou","year":"2015","unstructured":"Economopoulou P, Dimitriadis G, Psyrri A (2015) Beyond BRCA: new hereditary breast cancer susceptibility genes. Cancer Treat Rev 41(1):1\u20138. doi: 10.1016\/j.ctrv.2014.10.008","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"4038_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10689-009-9295-z","volume":"9","author":"L Papi","year":"2010","unstructured":"Papi L, Putignano AL, Congregati C, Piaceri I, Zanna I, Sera F, Morrone D, Genuardi M, Palli D (2010) A PALB2 germline mutation associated with hereditary breast cancer in Italy. Fam Cancer 9(2):181\u2013185. doi: 10.1007\/s10689-009-9295-z","journal-title":"Fam Cancer"},{"issue":"4","key":"4038_CR34","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/hmg\/ddi052","volume":"14","author":"A Shaag","year":"2005","unstructured":"Shaag A, Walsh T, Renbaum P, Kirchhoff T, Nafa K, Shiovitz S, Mandell JB, Welcsh P, Lee MK, Ellis N, Offit K, Levy-Lahad E, King MC (2005) Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population. Hum Mol Genet 14(4):555\u2013563. doi: 10.1093\/hmg\/ddi052","journal-title":"Hum Mol Genet"},{"issue":"11","key":"4038_CR35","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/humu.20415","volume":"27","author":"JL Bernstein","year":"2006","unstructured":"Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P (2006) Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry. Hum Mutat 27(11):1122\u20131128. doi: 10.1002\/humu.20415","journal-title":"Hum Mutat"},{"key":"4038_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12710","author":"NJ Os van","year":"2015","unstructured":"van Os NJ, Roeleveld N, Weemaes CM, Jongmans MC, Janssens GO, Taylor AM, Hoogerbrugge N, Willemsen MA (2015) Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline. Clin Genet. doi: 10.1111\/cge.12710","journal-title":"Clin Genet"},{"issue":"7","key":"4038_CR37","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/ijd.12408","volume":"53","author":"H Arora","year":"2014","unstructured":"Arora H, Chacon AH, Choudhary S, McLeod MP, Meshkov L, Nouri K, Izakovic J (2014) Bloom syndrome. Int J Dermatol 53(7):798\u2013802. doi: 10.1111\/ijd.12408","journal-title":"Int J Dermatol"},{"issue":"2","key":"4038_CR38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10549-012-2357-1","volume":"137","author":"D Prokofyeva","year":"2013","unstructured":"Prokofyeva D, Bogdanova N, Dubrowinskaja N, Bermisheva M, Takhirova Z, Antonenkova N, Turmanov N, Datsyuk I, Gantsev S, Christiansen H, Park-Simon TW, Hillemanns P, Khusnutdinova E, Dork T (2013) Nonsense mutation p. Q548X in BLM, the gene mutated in Bloom\u2019s syndrome, is associated with breast cancer in Slavic populations. Breast Cancer Res Treat 137(2):533\u2013539. doi: 10.1007\/s10549-012-2357-1","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"4038_CR39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10549-014-2971-1","volume":"145","author":"AP Sokolenko","year":"2014","unstructured":"Sokolenko AP, Bogdanova N, Kluzniak W, Preobrazhenskaya EV, Kuligina ES, Iyevleva AG, Aleksakhina SN, Mitiushkina NV, Gorodnova TV, Bessonov AA, Togo AV, Lubinski J, Cybulski C, Jakubowska A, Dork T, Imyanitov EN (2014) Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN\/NBS1, and BLM germ-line mutations. Breast Cancer Res Treat 145(2):553\u2013562. doi: 10.1007\/s10549-014-2971-1","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"4038_CR40","doi-asserted-by":"publisher","first-page":"e1002894","DOI":"10.1371\/journal.pgen.1002894","volume":"8","author":"ER Thompson","year":"2012","unstructured":"Thompson ER, Doyle MA, Ryland GL, Rowley SM, Choong DY, Tothill RW, Thorne H, Barnes DR, Li J, Ellul J, Philip GK, Antill YC, James PA, Trainer AH, Mitchell G, Campbell IG (2012) Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS Genet 8(9):e1002894. doi: 10.1371\/journal.pgen.1002894","journal-title":"PLoS Genet"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-4038-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-4038-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-4038-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:26:50Z","timestamp":1498343210000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-4038-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,31]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["4038"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-4038-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,31]]}}}